Renal
The abbreviated and micro formats do not require turnover, and these accounts state none. Without turnover there is no EBIT margin either.
Balance sheet
balance sheet total €270,807 on 31-12-2025in euro
in euro
Position in the sector
89.8%
Higher than 89% of the 10,299 companies filing micro accounts in office administrative support (NACE 82) in 2025.
9.50
Higher than 90% of the 9,879 companies filing micro accounts in office administrative support (NACE 82) in 2025.
-11.6%
Higher than 11% of the 10,021 companies filing micro accounts in office administrative support (NACE 82) in 2025.
Net result: bottom quarter · Equity: top quarter · Balance sheet total: middle half · Working capital: top quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| -16,915 | 79,473 | 69,184 | 78,611 | 98,887 | 96,877 | ||
| -16,396 | 61,110 | 52,660 | 58,808 | 71,718 | 71,823 | ||
| 0 | 17,000 | 1,295 | 29,470 | 8,711 | - | ||
| -111,570 | 71,893 | 50,696 | -3,613 | 30,306 | - | ||
| 235,805 | 252,201 | 208,091 | 156,725 | 126,495 | 63,488 | ||
| 89.8% | 93.5% | 99.7% | 97.1% | 69.9% | 69.4% | ||
| 9.50 | 14.16 | - | 28.84 | 3.15 | 3.08 | ||
| 0.11 | 0.07 | 0.00 | 0.03 | 0.43 | 0.44 | ||
| -13.0% | 16.5% | 17.4% | 27.9% | 49.3% | 101.5% | ||
| -11.6% | 15.4% | 17.4% | 27.1% | 34.4% | 70.4% | ||
| -94.56 | over 100 | over 100 | over 100 | over 100 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Balance sheet: assets | |||||||
20/58 |
270,807 | 293,751 | 230,174 | 195,037 | 195,454 | 99,779 | |
21/28 |
7,255 | 22,385 | 21,317 | 32,682 | 10,070 | 5,748 | |
22/27 |
6,775 | 21,905 | 20,837 | 32,202 | 9,590 | 5,748 | |
23 |
332 | 779 | 2,072 | 1,916 | 2,054 | - | |
24 |
6,443 | 21,126 | 18,764 | 30,286 | 7,536 | 5,748 | |
28 |
480 | 480 | 480 | 480 | 480 | - | |
29/58 |
263,551 | 271,365 | 208,857 | 162,355 | 185,384 | 94,031 | |
40/41 |
153,081 | 50,081 | 59,579 | 63,002 | 80,617 | 20,696 | |
40 |
720 | 14,936 | 22,940 | 22,190 | 15,731 | 19,138 | |
41 |
152,361 | 35,144 | 36,640 | 40,812 | 64,886 | 1,558 | |
54/58 |
107,365 | 218,935 | 147,042 | 96,346 | 99,959 | 69,653 | |
490/1 |
3,105 | 2,350 | 2,236 | 3,007 | 4,808 | 3,682 | |
| Balance sheet: equity and liabilities | |||||||
10/49 |
270,807 | 293,751 | 230,174 | 195,037 | 195,454 | 99,779 | |
10/15 |
243,060 | 274,586 | 229,407 | 189,407 | 136,565 | 69,235 | |
10/11 |
1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | |
13 |
273,586 | 273,586 | 228,407 | 188,407 | 135,565 | 68,235 | |
133 |
273,586 | 273,586 | 228,407 | 188,407 | 135,565 | 68,235 | |
14 |
-31,526 | - | - | - | - | - | |
17/49 |
27,746 | 19,164 | 766 | 5,630 | 58,889 | 30,544 | |
42/48 |
27,746 | 19,164 | 766 | 5,630 | 58,889 | 30,544 | |
44 |
- | 1,652 | 766 | 2,850 | 1,600 | 1,150 | |
440/4 |
- | 1,652 | 766 | 2,850 | 1,600 | 1,150 | |
45 |
13,597 | 14,265 | - | 364 | 52,646 | 25,291 | |
450/3 |
13,597 | 14,265 | - | 364 | 52,646 | 25,291 | |
47/48 |
14,149 | 3,247 | - | 2,416 | 4,642 | 4,102 | |
| Income statement | |||||||
76A |
- | - | - | 2,108 | - | - | |
9900 |
-15,406 | 81,105 | 72,860 | 80,107 | 100,941 | 98,369 | |
630 |
15,130 | 15,931 | 12,660 | 5,966 | 4,389 | 1,545 | |
640/8 |
1,509 | 1,632 | 3,676 | 1,496 | 2,054 | 1,492 | |
9901 |
-32,045 | 63,542 | 56,524 | 72,645 | 94,498 | 95,332 | |
75/76B |
1,053 | 548 | 555 | 766 | 682 | 71 | |
75 |
1,053 | 548 | 555 | 766 | 682 | 71 | |
65/66B |
179 | 280 | 237 | 205 | 180 | 149 | |
65 |
179 | 280 | 237 | 205 | 180 | 149 | |
9903 |
-31,171 | 63,809 | 56,842 | 73,206 | 95,000 | 95,254 | |
67/77 |
355 | 18,630 | 16,841 | 20,364 | 27,670 | 24,976 | |
9904 |
-31,526 | 45,179 | 40,000 | 52,842 | 67,329 | 70,278 | |
9905 |
-31,526 | 45,179 | 40,000 | 52,842 | 67,329 | 70,278 | |
| Appropriation of the result | |||||||
9906 |
-31,526 | 45,179 | 40,000 | 52,842 | 67,329 | 68,235 | |
691/2 |
- | 45,179 | 40,000 | 52,842 | 67,329 | 68,235 | |
6921 |
- | 45,179 | 40,000 | 52,842 | 67,329 | 68,235 | |
| Document | |||||||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 10-08-2026.
Filings
each dot is a set of accounts, on the day it reached the National BankThe accounts were filed on 10-08-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00390175.
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 10-08-2026 | 2026-00390175 | |
| 31-12-2024 | abbreviated format | 04-07-2025 | 2025-00230106 | |
| 31-12-2023 | abbreviated format | 20-07-2024 | 2024-00266238 | |
| 31-12-2022 | abbreviated format | 08-07-2023 | 2023-00217446 | |
| 31-12-2021 | abbreviated format | 20-06-2022 | 2022-20072632 | |
| 31-12-2020 | abbreviated format | 21-06-2021 | 2021-21800376 |
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | €17,000 | €1,295 | €29,470 | €8,231 |
| Financial fixed assets | - | - | - | - | €480 |
| €15,130 | €15,931 | €12,660 | €5,966 | €4,389 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on Renal
The operating result for 2025 is a loss of €32,045, after a profit of €63,542 in 2024. It is the lowest result since 2020.
Debt's share of the balance-sheet total rises from 6.5% to 10.2%. Equity is lower and debt is higher.